The Current Ratio of Alphamab Oncology (9966.HK) is 5.84.
Current Ratio compares a firm's current assets to its current liabilities to assess short-term liquidity. A ratio above 1.0 typically indicates a strong ability to meet obligations.
| Date | Value |
|---|---|
| 2024-12-31 | 5.84 |
| 2023-12-31 | 5.84 |
| 2022-12-31 | 3.88 |
| 2021-12-31 | 3.32 |
| 2020-12-31 | 6.67 |
| 2019-12-31 | 12.19 |
| 2018-12-31 | 7.92 |
| 2017-12-31 | 1.09 |